Aetna Inc. Stock
Your prediction
Pros and Cons of Aetna Inc. in the next few years
Pros
Cons
Performance of Aetna Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Aetna Inc. | - | - | - | - | - | - | - |
| Cigna Corp. | -2.940% | -4.258% | -2.969% | 8.116% | 4.520% | -6.771% | 24.290% |
| Humana Inc. | -2.450% | -2.976% | -6.322% | 52.550% | 48.452% | -26.758% | -9.116% |
| UnitedHealth Group Inc. | -1.720% | -1.742% | -1.742% | 75.712% | 28.837% | -21.777% | 1.519% |
News
ARS Pharmaceuticals Q1 Earnings Call Highlights
ARS Pharmaceuticals (NASDAQ:SPRY) reported first-quarter 2026 revenue of $22.7 million as executives said the company is working to expand access, reduce prescribing friction and build momentum for
CVS Health Q1 Earnings Call Highlights
CVS Health (NYSE:CVS) raised its full-year 2026 adjusted earnings outlook after reporting stronger first-quarter results, with
Is CVS Health the Ultimate Value Stock to Buy Right Now?
Shares of CVS Health (NYSE: CVS) have lagged the S&P 500 in total return this year, reinforcing a familiar narrative about the healthcare company: a mature, slow-growing grinder.
However, that view


